Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2023
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 CasesToru Odate, Kaishi Satomi, Takashi Kubo, et al.Nature Communications|December 21, 2019
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutationsSatoshi Inoue, Yasushi Hirota, Toshihide Ueno, et al.Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunityFumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.Blood|February 14, 2018
Integrated molecular profiling of juvenile myelomonocytic leukemiaNorihiro Murakami, Yusuke Okuno, Kenichi Yoshida, et al.Plos Genetics|June 22, 2017
Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiencyMasahito Kawazu, Shinya Kojima, Toshihide Ueno, et al.Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.Nature Genetics|March 29, 2016
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adultsTakahiko Yasuda, Shinobu Tsuzuki, Masahito Kawazu, et al.Blood Cancer Discovery|October 18, 2021
Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic LeukemiaShinobu Tsuzuki, Takahiko Yasuda, Shinya Kojima, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade GliomaJo Sasame, Naoki Ikegaya, Masahito Kawazu, et al.Nature Immunology|September 2, 2020
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.Pageof 10